Home Newsfeeds Wolfe Research Initiates Coverage On Teleflex with Outperform Rating

Wolfe Research Initiates Coverage On Teleflex with Outperform Rating

Wolfe Research analyst Mike Polark initiates coverage on Teleflex (NYSE:TFX) with a Outperform rating.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Wolfe Research analyst Mike Polark initiates coverage on Teleflex (NYSE:TFX) with a Outperform rating.

Silo Pharma’s New Ketamine Implant For Fibromyalgia And Chronic Pain Is In The Making

By Lara Goldstein

June 13, 2:05 PM

Developmental-stage psychedelics biotech Silo Pharma (NASDAQ: SILO) has entered into a research and development agreement to study and develop a dosage and time-release ketamine implant with fibromyalgia and chronic pain as the initially targeted indications.

SILO

Truecar Announces Strategic Restructuring And Leadership Transition; Impacting 102 Positions, Or 24% Of Co, Expected To Streamline Organization And Reduce Annualized Expenses By Over $20M; Jantoon Reigersman Appointed President And Chief Executive Offi…

By Benzinga Newsdesk

June 14, 4:08 PM

Restructuring Expected to Streamline Organization and Reduce Annualized Expenses by Over $20 MillionJantoon Reigersman Appointed President and Chief Executive OfficerMichael Darrow to Depart from CompanySANTA MONICA,

TRUE